The effect of age and comorbidity on patient-centered health outcomes in patients receiving adjuvant chemotherapy for colon cancer

Journal of Geriatric Oncology

Volumn 4, Issue 2, 2013, Pages 99-106

  Hermosillo Rodriguez, Jesus ^b   Anaya, Daniel A ^a,b   Sada, Yvonne ^b   Walder, Annette ^a   Amspoker, Amber B ^a,b   Berger, David H ^a,b   Naik, Aanand D ^a,b  

^a MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Adjuvant; Chemotherapy; Colon; Comorbidity; Health care utilization; Living situation; Older adults; Patient centered; Readmissions

Indexed keywords

ANTINEOPLASTIC AGENT; BEVACIZUMAB; CAPECITABINE; CETUXIMAB; FLUOROURACIL; FOLINIC ACID; OXALIPLATIN;

ADJUVANT THERAPY; AGE; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER PATIENT; CANCER STAGING; CHRONIC OBSTRUCTIVE LUNG DISEASE; COLON CANCER; COLORECTAL CANCER; COMORBIDITY; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HEALTH CARE UTILIZATION; HIGH RISK PATIENT; HOME CARE; HUMAN; MAJOR CLINICAL STUDY; MULTIPLE CYCLE TREATMENT; NURSING HOME; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE;

ADENOCARCINOMA; AGE FACTORS; AGED; AGED, 80 AND OVER; CHEMOTHERAPY, ADJUVANT; COLONIC NEOPLASMS; COMORBIDITY; DIABETES MELLITUS; EMERGENCY SERVICE, HOSPITAL; FEMALE; HUMANS; INDEPENDENT LIVING; MALE; MULTIVARIATE ANALYSIS; PATIENT ADMISSION; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 84875592662     PISSN: 18794068     EISSN: 18794076     Source Type: Journal    
DOI: 10.1016/j.jgo.2012.12.004     Document Type: Article

References (33)

1. Jemal A., Siegel R., Xu J., Ward E. Cancer statistics, 2010. CA Cancer J Clin Sep-Oct 2010, 60(5):277-300. [Epub 2010 Jul 7].
2. NIH consensus reference Adjuvant therapy for patients with colon and rectal cancer. JAMA 1990, 264:1444-1450.
3. National Comprehensive Cancer Network (NCCN) guidelines Available at:, [Accessed on August 08, 2011]. http://www.nccn.org.
4. Cheema F.N., Abraham N.S., Berger D.H., Albo D., Taffet G.E., Naik A.D. Novel approaches to perioperative assessment and intervention may improve long-term outcomes after colorectal cancer resection in older adults. Ann Surg May 2001, 253(5):867-874.
5. Anaya D.A., Becker N.S., Abraham N.S. Global graying, colorectal cancer and liver metastasis: new implications for surgical management. Crit Rev Oncol Hematol Feb 2011, 77(2):100-108. [Epub 2010 Mar 4].
6. Jessup J.M., Stewart A., Greene F.L., Minsky B.D. Adjuvant chemotherapy for stage III colon cancer. JAMA 2005, 294(21):2703-2711.
7. Schrag D., Cramer L.D., Bach P.B., Begg C.B. Age and adjuvant chemotherapy use after surgery for stage III colon cancer. J Natl Cancer Inst Jun 6 2001, 93(11):850-857.
8. Mahoney T., Kuo Y.H., Topilow A., Davis J.M. Stage III colon cancers: why adjuvant chemotherapy is not offered to elderly patients. Arch Surg 2000, 135:182-185.
9. Lemmens V., Van Halteren A., Janssen-Heijnen M., Vreugdenhil G., Repelaer van Driel O.J., Coebergh J.W.W. Adjuvant treatment for elderly patients with stage III colon cancer in the Southern Netherlands is affected by socioeconomic status, gender, and comorbidity. Ann Oncol May 2005, 16(5):767-772.
10. Hynes D., Tarlov E., Durazo-Arvizu R., Perrin R., Zhang Q., Weichle T., et al. Surgery and adjuvant chemotherapy use among veterans with colon cancer: insights from a California study. J Clin Oncol May 20 2010, 28(15):2571-2576.
11. Hershman D., Hall M., Wang X., Jacobson J.S., McBride R., Grann V.R., et al. Timing of adjuvant chemotherapy initiation after surgery for stage III colon cancer. Cancer Dec 1 2006, 107(11):2581-2588.
12. Ong S., Watters J., Grunfeld E., O'Rourke K., et al. Predictors of referral for adjuvant therapy for colorectal cancer. Can J Surg Jun 2005, 48(3):225-229.
13. Van Steenbergen L.N., Rutten H.J.T., Creemers G.J., Pruijt J.F., Coebergh J.W., Lemmens V.E., et al. Large age and hospital-dependent variation in administration of adjuvant chemotherapy for stage III colon cancer in southern Netherlands. Ann Oncol Jun 2010, 21(6):1273-1278. [Epub 2009 Oct 30].
14. Hu C.Y., Delclos G., Chan W., Du X.L. Assessing the initation and completion of adjuvant chemotherapy in a large nationwide and population-based cohort of elderly patients with stage III colon cancer. Med Oncol Dec 2011, 28(4):1062-1074.
15. Sargent D., Golberg R., Jacobson S., Macdonald J.S., Labianca R., Haller D.G., et al. A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patients. N Engl J Med Oct 11 2001, 345(15):1091-1097.
16. Iwashyna T., Lamont E. Effectiveness of adjuvant fluorouracil in clinical practice: a population-based cohort study of elderly cancer patients with stage III colon cancer. J Clin Oncol Oct 1 2002, 20(19):3992-3998.
17. Popescu A., Norman P.J., Ross B., Parikh B., Cunningham D. Adjuvant or palliative chemotherapy for colorectal cancer in patients 70years or older. J Clin Oncol Aug 1999, 17(8):2412-2418.
18. Twelves C., Wong A., Nowacki M., Abt M., Burris H., Carrato A., et al. Capecitabine as adjuvant treatment for stage III colon cancer. N Engl J Med 2005, 352:2696-2704.
19. Gross C., McAvay G., Krumholz H., Paltiel A.D., Bhasin D., Tinetti M.E. The effect of age and chronic illness on life expectancy after a diagnosis of colorectal cancer: implications for screening. Ann Intern Med Nov 7 2006, 145(9):646-653.
20. Sarfati D., Hill S., Blakely T., Robson B., Purdie G., Dennett E., et al. The effect of comorbidity on the use of adjuvant chemotherapy and survival from colon cancer: a retrospective cohort study. BMC Cancer Apr 20 2009, 9:116.
21. Gross C., McAvay G., Guo Z., Tinetti M.E. The impact of chronic illness on the use and effectiveness of adjuvant chemotherapy for colon cancer. Cancer Jun 15 2007, 109(12):2410-2419.
22. Koroukian S. Assessment and interpretation of comorbidity burden in older adults with cancer. J Am Geriatr Soc Nov 2009, 57(Suppl. 2):S275-S278.
23. Janssen-Heijnen M., Houterman S., Lemmens V., Louwman M.W., Maas H.A., Coebergh J.W. Prognostic impact of increasing age and comorbidity in cancer patients: a population-based approach. Crit Rev Oncol Hematol Sept 2005, 55(3):231-240.
24. Ouellette J., Small D., Termublen P. Evaluation of Charlson-Age Comorbidity Index as predictor of morbidity and mortality in patients with colorectal carcinoma. J Gastrointest Surg Dec 2004, 8(8):1061-1067.
25. Yancik R., Wesley M., Ries L., Havlik R.J., Long S., Edwards B.K., et al. Comorbidity and age as predictors of risk for early mortality of male and female colon carcinoma patients: a population-based study. Cancer Jun 1 1998, 82(11):2123-2134.
26. Lemmens V.E., Janssen-Heijnen M.L., Verheij C.D., Houterman S., Repelaer van Driel O.J., Coebergh J.W. Comorbidity leads to altered treatment and worse survival of elderly patients with colorectal cancer. Br J Surg May 2005, 92(5):615-623.
27. Stiggelbout A.M., de Haes J.C., Kiebert G.M., Kievit J., Leer J.W. Tradeoffs between quality and quantity of life: development of the QQ questionnaire for cancer patient attitudes. Med Decis Making 1996, 16:184-192.
28. Gill T., Gahbauer E., Murphy T., Han L., Allore H.G. Risk factors and precipitants of long-term disability in community mobility: a cohort study of older persons. Ann Intern Med 2012, 156(2):131-140.
29. Wan-Chow-Wah D., Monette J., Monette M., Sourial N., Retornaz F., Batist G., et al. Difficulties in decision making regarding chemotherapy for older cancer patients: a census of cancer physicians. Crit Rev Oncol Hematol Apr 2011, 78(1):45-58. [Epub 2010 Mar 23].
30. Freye G., Geay J.F., Touzet S., Provencal J., Weber B., Jacquin J.P., et al. Comprehensive geriatric assessment predicts tolerance to chemotherapy and survival in elderly patients with advanced ovarian carcinoma: a GINECO study. Ann Oncol 2005 Nov, 16(11):1795-1800. [Epub 2005 Aug 10].
31. Charlson M., Pompei P., Ales K., MacKenzie C.R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987, 40(5):373-383.
32. Andre T., Boni C., Mounedji-Boudiaf L., Navarro M., Tabernero J., Hickish T., et al. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med 2004, 350:2343-2351.
33. Hurria A., Togawa K., Mohile S., Owusu C., Klepin H.D., Gross C.P., et al. Predicting chemotherapy toxicity in older adults with cancer: a prospective multicenter study. J Clin Oncol Sep 1 2011, 29(25):3457-3465.